Source:http://linkedlifedata.com/resource/pubmed/id/21289927
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2011-2-3
|
pubmed:abstractText |
In-stent-restenosis (ISR) is considered to be an essential limiting factor of stenting in coronary heart disease (CHD). The development of coated stents has raised expectations on substantial lowering restenosis after stenting with decreasing the rate of restenosis and a reduction in the rate of clinical events.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:issn |
1861-8863
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
Doc06
|
pubmed:year |
2005
|
pubmed:articleTitle |
Coated stents to prevent restenosis in coronary heart disease.
|
pubmed:affiliation |
Medizinische Hochschule Hannover, Abteilung Epidemiologie, Sozialmedizin und Gesundheitssystemforschung, Hannover, Deutschland.
|
pubmed:publicationType |
Journal Article
|